Animal models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis

被引:410
|
作者
Takahashi, Yoshihisa [1 ]
Soejima, Yurie [1 ]
Fukusato, Toshio [1 ]
机构
[1] Teikyo Univ, Sch Med, Dept Pathol, Itabashi Ku, Tokyo 1738605, Japan
关键词
Animal model; Nonalcoholic fatty liver disease; Nonalcoholic steatohepatitis; Metabolic syndrome; Histopathology; ACTIVATED-RECEPTOR-ALPHA; CHOLINE-DEFICIENT DIET; METHIONINE ADENOSYLTRANSFERASE 1A; FRUCTOSE-ENRICHED DIETS; INSULIN-RESISTANCE; METABOLIC SYNDROME; DB/DB MICE; HEPATIC INFLAMMATION; OXIDATIVE STRESS; NATURAL-HISTORY;
D O I
10.3748/wjg.v18.i19.2300
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Nonalcoholic fatty liver disease (NAFLD) is a condition in which excess fat accumulates in the liver of a patient without a history of alcohol abuse. Nonalcoholic steatohepatitis (NASH), a severe form of NAFLD, can progress to liver cirrhosis and hepatocellular carcinoma. NAFLD is regarded as a hepatic manifestation of metabolic syndrome and incidence has been increasing worldwide in line with the increased prevalence of obesity, type 2 diabetes, and hyperlipemia. Animal models of NAFLD/NASH give crucial information, not only in elucidating pathogenesis of NAFLD/NASH but also in examining therapeutic effects of various agents. An ideal model of NAFLD/NASH should correctly reflect both hepatic histopathology and pathophysiology of human NAFLD/NASH. Animal models of NAFLD/NASH are divided into genetic, dietary, and combination models. In this paper, we review commonly used animal models of NAFLD/NASH referring to their advantages and disadvantages. (c) 2012 Baishideng. All rights reserved.
引用
收藏
页码:2300 / 2308
页数:9
相关论文
共 50 条
  • [1] Animal models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
    Yoshihisa Takahashi
    Yurie Soejima
    Toshio Fukusato
    World Journal of Gastroenterology, 2012, (19) : 2300 - 2308
  • [2] Rodent Models of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis
    Imajo, Kento
    Yoneda, Masato
    Kessoku, Takaomi
    Ogawa, Yuji
    Maeda, Shin
    Sumida, Yoshio
    Hyogo, Hideyuki
    Eguchi, Yuichiro
    Wada, Koichiro
    Nakajima, Atsushi
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2013, 14 (11) : 21833 - 21857
  • [4] Histopathology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
    Brown, Gregory Thomas
    Kleiner, David E.
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2016, 65 (08): : 1080 - 1086
  • [5] Histopathology of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
    Takahashi, Yoshihisa
    Fukusato, Toshio
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (42) : 15539 - 15548
  • [6] Pathophysiological Features of Rat Models of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis
    Saigo, Yasuka
    Uno, Kinuko
    Ishigure, Tatsuya
    Odake, Tatsumi
    Ohta, Takeshi
    IN VIVO, 2024, 38 (03): : 990 - 999
  • [7] Pathophysiology of Nonalcoholic Fatty Liver Disease/Nonalcoholic steatohepatitis
    Manne, Vignan
    Handa, Priya
    Kowdley, Kris V.
    CLINICS IN LIVER DISEASE, 2018, 22 (01) : 23 - +
  • [8] Histopathology of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
    Yoshihisa Takahashi
    Toshio Fukusato
    World Journal of Gastroenterology, 2014, (42) : 15539 - 15548
  • [9] Metformin for Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
    Farah, Samira
    Thu Nguyen
    Kelsberg, Gary
    Safranek, Sarah
    AMERICAN FAMILY PHYSICIAN, 2019, 99 (04) : 262 - 263
  • [10] Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis in Japan
    Okanoue, Takeshi
    Umemura, Atsushi
    Yasui, Kohichiroh
    Itoh, Yoshito
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2011, 26 : 153 - 162